Mechanisms of viral clearance and persistence
- 1 November 1997
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 4 (s2) , 16-24
- https://doi.org/10.1111/j.1365-2893.1997.tb00176.x
Abstract
Using examples predominantly drawn from study of the lymphocytic choriomeningitis virus (LCMV) model system, this review describes the mechanisms involved in control of virus infections by the cell-mediated immune response, and some of the different strategies viruses have evolved to evade such immune clearance so that they can persist in their hosts. The important role played by the CD8+ cytotoxic lymphocyte (CTL) response in clearance of many systemic virus infections is discussed; and it is emphasized that although CD8+ CTL are classically thought of as lymphocytes which mediate lysis of virus-infected target cells, the principal mechanism by which CD8+ T cells effect clearance of persistent and many acute virus infections via production of antiviral cytokines such as tumour necrosis factor-alpha and interferon-gamma, not via destruction of virus-producing cells. To avoid immune-mediated clearance, viruses frequently use a combination of several different strategies. These can be grouped into mechanisms for avoiding recognition by the immune response (such as establishing latent infections, replicating in immune-privileged sites, down-regulating the expression of immune recognition signals on the surface of infected cells, or undergoing antigenic variation); and mechanisms for suppressing the immune response. The latter include generalized immune suppression mechanisms, and strategies for more precisely disabling the specific immune response such as inducing tolerance or exhaustion of virus-specific CTL. The value of understanding both immune clearance mechanisms and viral evasion strategies in the rational design of immune-based therapies to combat persistent virus infections is discussedKeywords
This publication has 55 references indexed in Scilit:
- A Single Residue Exchange Within a Viral CTL Epitope Alters Proteasome-Mediated Degradation Resulting in Lack of Antigen PresentationImmunity, 1996
- Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T LymphocytesImmunity, 1996
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- The Role of CD4+ T Cells in Cell‐Mediated Immunity to LCM V: Studies in MHC Class I and Class II Deficient MiceScandinavian Journal of Immunology, 1994
- T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDSImmunology Today, 1994
- HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + PopulationScience, 1993
- LCMV-Specific, Class II-Restricted Cytotoxic T Cells in β2-Microglobulin-Deficient MiceScience, 1992
- Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4Nature, 1991
- An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigensCell, 1985
- Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasiaImmunology Today, 1984